Evidence map›Paper›PMID 39678347›Full record

ArticleResearch square2024

Identification of specific microbiota members that induce beige fat biogenesis in response to dietary cues.

Kenya Honda, Takeshi Tanoue, Manabu Nagayama, Ayumi Roochana, Samuel Zimmerman, Orr Ashenberg, Tanvi Jain, Satoshi Sasajima, Kozue Takeshita, Nicola Hetherington and 20 more

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Kenya HondaKeio University School of Medicine.ORCID 0000-0001-8937-9835
Takeshi TanoueKeio University School of Medicine.ORCID 0000-0003-3639-8834
Manabu NagayamaKeio University School of Medicine.
Ayumi RoochanaKeio University School of Medicine.
Samuel ZimmermanInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard.
Orr AshenbergBroad Institute of MIT and Harvard.
Tanvi JainKlarman Cell Observatory, Broad Institute of MIT and Harvard.
Satoshi SasajimaKeio University School of Medicine.
Kozue TakeshitaKeio University School of Medicine.
Nicola HetheringtonRIKEN Center for Integrative Medical Sciences.
Nobuyuki OkahashiRIKEN.
Masahiro UedaRIKEN Center for Integrative Medical Sciences.
Morichika KonishiKobe Pharmaceutical University.ORCID 0000-0002-2424-7169
Yoshiaki NakayamaLaboratory of Microbial Chemistry, Kobe Pharmaceutical University.
Aki MinodaRIKEN.
Ashwin SkellyKeio University School of Medicine.ORCID 0000-0002-1565-3376
Yasuhiko MinokoshiNational Institute for Physiological Sciences.
Nicholas PucciDepartment of Medical Microbiology, Amsterdam UMC, University of Amsterdam.
Daniel MendeDepartment of Medical Microbiology, Amsterdam UMC, University of Amsterdam.
Makoto AritaRIKEN Center for Integrative Medical Sciences.ORCID 0000-0001-9902-0463
Hironori YamamotoDivision of Gastroenterology, Department of Medicine, Jichi Medical University.
Shunji WatanabeDivision of Gastroenterology, Department of Medicine, Jichi Medical University.
Kouichi MiuraDivision of Gastroenterology, Department of Medicine, Jichi Medical University.
Wataru SudaRIKEN Center for Integrative Medical Sciences.
Koji AtarashiKeio University School of Medicine.ORCID 0000-0001-5422-0736
Mami MatsushitaTenshi College.
Shingo KajimuraBeth Israel Deaconess Medical Center, Harvard Medical School, and Howard Hughes Medical Institute.ORCID 0000-0003-0672-5910
Damian PlichtaBroad Institute.ORCID 0000-0002-6555-2557
Masayuki SaitoHokkaido University.
Ramnik XavierMassachusetts General Hospital.ORCID 0000-0002-5630-5167

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Determinants of inception of inflammation in inflammatory bowel diseasesR01DK127171 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ANANTHAKRISHNAN, ASHWIN N, XAVIER, RAMNIK J · 2021 to 2025
$5.4M
Identification and Characterization of Microbial Metabolites in ImmunityR01AI172147 · NIAID · BROAD INSTITUTE, INC. · PI Daniel Bartholomew Graham, Ramnik J Xavier · 2022 to 2026
$3.9M
Cardiovascular disease, metabolic syndrome, microbes and metabolites in FHSR01HL157717 · NHLBI · BROAD INSTITUTE, INC. · PI XAVIER, RAMNIK J · 2022 to 2025
$3.9M
NHLBI NIH HHS R01 HL157717NIAID NIH HHS R01 AI172147NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK127171Wellcome Trust
6 · The paper itself

Abstract

Activation of brown and beige fat biogenesis promotes metabolic health in rodents and humans, but typically requires cold exposure or pharmacological activation of β-adrenergic receptors, which may pose cardiovascular risks. Dietary intervention represents a clinically viable alternative strategy to induce beige cells and thus enhance metabolic health, though the underlying mechanisms remain poorly understood. In this study, we identified specific microbiota members in both mice and humans that promote browning of white adipose tissue (WAT) and ameliorate metabolic disorders in the context of a low-protein diet (LPD). Diets with low protein, regardless of fat and carbohydrate content, induced robust WAT browning to a degree comparable to that achieved by cold exposure or β-adrenergic receptor agonist administration. LPD-mediated browning was markedly diminished in germ-free (GF) mice, highlighting the essential role of the gut microbiota. Microbiota-induced browning occurred independently of the immune system and primarily through mechanisms involving increased circulating deconjugated bile acids, activation of the farnesoid X receptor (FXR) in WAT progenitor cells, and enhanced hepatic production of FGF21. The browning defect in GF mice was rescued by transplanting microbiota from conventional mice or from brown/beige fat-positive healthy human volunteers, as determined by fluorodeoxyglucose positron-emission tomography (FDG-PET). Defined bacterial consortia, comprising strains isolated from mice or FDG-PET-positive human volunteers, were sufficient to elevate plasma bile acids and hepatic FGF21 levels by modulating nitrogen metabolism, ultimately restoring browning in response to a LPD. Our findings highlight the significant impact of diet-microbiota interactions on WAT browning and suggest their therapeutic potential for managing metabolic diseases.

Identifiers

PMID39678347
PMCPMC11643319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.